O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Ruichang International Holdings Limited on the transaction. Ruichang International Holdings Limited (1334.HK) announced its initial public offering and listing on the Main Board of...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati acted as TuanChe’s U.S. counsel in this transaction. TuanChe Limited, a leading integrated automotive marketplace in China, announced the closing of its...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
You must be a Standard 1 Year member to access this content.
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
You must be a Standard 1 Year member to access this content.
